Between Bedside and Bench | Published:

A MRSA-terious enemy among us: End of the PVL controversy?

Nature Medicine volume 17, pages 169170 (2011) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. J. Am. Med. Assoc. 298, 1763–1771 (2007).

  2. 2.

    et al. Clin. Infect. Dis. 29, 1128–1132 (1999).

  3. 3.

    , et al. J. Clin. Microbiol. 47, 3952–2957 (2009).

  4. 4.

    , , , & J. Infect. Dis. 198, 1166–1170 (2008).

  5. 5.

    et al. J. Infect. Dis. 194, 1761–1770 (2006).

  6. 6.

    et al. Emerg. Infect. Dis. 9, 978–984 (2003).

  7. 7.

    Annu. Rev. Microbiol. 64, 143–162 (2010).

  8. 8.

    , , , & Antimicrob. Agents Chemother. 51, 3381–3384 (2007).

  9. 9.

    , & Clin. Infect. Dis. 51, 1138–1146 (2010).

  10. 10.

    et al. J. Infect. Dis. 202, 1866–1876 (2010).

  11. 11.

    et al. PLoS Pathog. 6, e1000715 (2010).

  12. 12.

    et al. PLoS ONE 4, e7204 (2009).

  13. 13.

    et al. Proc. Natl. Acad. Sci. USA 107, 5587–5592 (2010)

  14. 14.

    et al. PLoS ONE 3, e3198 (2008).

  15. 15.

    et al. J. Infect. Dis. 186, 1344–1347 (2002).

Download references

Author information

Affiliations

  1. Michael Otto is at the US National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

    • Michael Otto

Authors

  1. Search for Michael Otto in:

Competing interests

The author declares no competing financial interests.

Corresponding author

Correspondence to Michael Otto.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nm0211-169

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing